Samsung Pharm Co Ltd banner

Intrinsic Value

The intrinsic value of Samsung Pharm Co Ltd (001360) under the Base Case is KRW per share. Compared with the current market price of 1 238 KRW, the stock appears .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

Samsung Pharm Co Ltd Intrinsic Value

What one share is worth in the bear, base and bull cases.

Create a free account · No card needed

Do our valuations actually work? See backtest results .

Alert me when Samsung Pharm Co Ltd is below its intrinsic value
Today Hidden ·
Samsung Pharm Co Ltd Valuation History

Intrinsic value next to the price over the past 5 years.

Create a free account · No card needed

Alternatives to Samsung Pharm Co Ltd

Fundamental Analysis

What Samsung Pharm Does

Pharmaceuticals Health Care

Samsung Pharm Co Ltd is a South Korean pharmaceutical company that makes and sells medicines and health-related products. Its line-up includes prescription drugs, over-the-counter remedies, and consumer health items that are sold through pharmacies, hospitals, clinics, and other distributors. The company’s business is straightforward: it develops or sources products, manufactures them, and sells them under its own brands.

Headquarters
Korea KR
Employees
83
IPO date
Jul 4, 1975
Read the full company overview
View Company Overview
Financials
Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue Research

Decided on Samsung Pharm? Get an email when Samsung Pharm Co Ltd reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one Samsung Pharm Co Ltd stock?

The intrinsic value for Samsung Pharm Co Ltd (001360) under the Base Case is KRW.

Is Samsung Pharm Co Ltd stock undervalued or overvalued?

Compared with the current market price of 1 238 KRW, the stock appears .

How reliable are our estimates? See how past valuations played out
Back to Top